UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000019828 |
|---|---|
| Receipt number | R000022906 |
| Scientific Title | A phase I study of irinotecan, bevacizumab and biweekly TAS-102 in Japanese patients with metastatic colorectal cancer refractory to fluoropyrimidine and oxaliplatin |
| Date of disclosure of the study information | 2015/12/15 |
| Last modified on | 2021/05/31 17:36:33 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2015/11/17 23:38:36 | ||
| 2 | Update | 2015/12/21 15:09:40 | Acronym Acronym |
|
| 3 | Update | 2016/05/25 18:18:59 | Name of primary person or sponsor Institute Institute Organization Organization Organization Category of Funding Organization |
|
| 4 | Update | 2016/11/16 09:40:51 | Recruitment status Date of protocol fixation Anticipated trial start date |
|
| 5 | Update | 2016/11/28 11:12:11 | Organization Organization Category of Funding Organization |
|
| 6 | Update | 2021/05/31 17:34:20 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
| 7 | Update | 2021/05/31 17:36:33 | Recruitment status Date of IRB Last follow-up date |
